S
Stockadora
Back to Insider Trading View Full Company Profile

SYRE

HEALTHY

Spyre Therapeutics, Inc.

CIK: 0001636282

Strong Sell (70% confidence)

Last activity: Mar 3, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$7.87M
Total Cash $756.50M

Insider Roster (2 total, 2 active)

Insider Buys Sells Net Value Holdings
Turtle Cameron
Chief Executive Officer
 		0 7 -$1.59M
642,540 shares
$27.30M
Burrows Scott L
Chief Financial Officer
 		0 2 -$102K
98,194 shares
$3.98M

Recent Transactions

SELL Burrows Scott L (Chief Financial Officer)

2,300 shares @ $40.56

$93K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Burrows Scott L (Chief Financial Officer)

200 shares @ $41.66

$8K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

9,100 shares @ $42.49

$387K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

5,900 shares @ $41.73

$246K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

14,043 shares @ $32.87

$462K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

957 shares @ $31.82

$30K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

12,709 shares @ $30.47

$387K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

2,191 shares @ $31.79

$70K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Turtle Cameron (Chief Executive Officer)

100 shares @ $32.39

$3K

Jan 2, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.